TABLE 2.
Unadjusted comparison of health service use, cost, and mortality outcomes in the follow‐up period in overall sample, and by race—advanced‐stage prostate cancer.
| All (N = 19,721) | White (n = 17,389) | AA (n = 2332) | p value | |
|---|---|---|---|---|
| ER visits, n (%) | ||||
| 0 | 9800 (49.7) | 8838 (50.8) | 962 (41.3) | <0.0001 |
| 1–3 | 7206 (36.5) | 6286 (36.2) | 920 (39.5) | |
| ≥4 | 2715 (13.8) | 2265 (13.0) | 450 (19.3) | |
| Hospitalizations, n (%) | ||||
| 0 | 1738 (8.8) | 1515 (8.7) | 233 (9.6) | <0.0001 |
| 1–3 | 10,910 (55.3) | 9768 (56.2) | 1142 (48.9) | |
| ≥4 | 7073 (35.9) | 6106 (35.1) | 967 (41.5) | |
| Total cost ($), mean ± SD | 40,139 ± 40,213 | 39,804 ± 39,037 | 42,639 ± 48,021 | 0.0014 |
| All‐cause mortality, n (%) | 12,520 (63.5) | 10,773 (61.9) | 1747 (74.9) | <0.0001 |
| Prostate cancer‐specific mortality, n (%) | 5262 (6.7) | 4395 (25.3) | 867 (37.2) | <0.0001 |
Abbreviations: ER, emergency room; SD, standard deviation.